A Phase 1b Dose Escalation Safety Analysis of Lenalidomide and Azacitidine Maintenance Therapy for Poor Risk AML

被引：0
|
作者：
Wei, Andrew H. [1 ]
Tan, Peter T. [2 ]
Walker, Patricia A. [2 ]
Avery, Sharon [2 ]
Patil, Sushrut S. [2 ]
Schwarer, Anthony P. [2 ]
Januszewicz, Elchanan H. [3 ]
Harrison, Simon J. [3 ]
Ho, Wai Khoon [4 ]
Tam, Constantine S. [5 ]
Spencer, Andrew
机构：
[1] Monash Univ, Alfred Hosp, Melbourne, Vic 3181, Australia
[2] Alfred Hosp, Dept Clin Haematol, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Dept Haematol & Oncol, Melbourne, Australia
[4] Austin Hlth, Dept Haematol, Melbourne, Australia
[5] St Vincents Hosp, Dept Haematol, Sydney, NSW, Australia
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1548 / 1549
页数：2
相关论文
共 50 条
  • [31] A Phase 1b Dose-Escalation Study of Split-Dose Oprozomib (ONX0912) in Patients with Hematologic Malignancies
    Savona, Michael R.
    Berdeja, Jesus G.
    Lee, Susan J.
    Wong, Hansen
    Lee, Ju RueyJiuan
    Gillenwater, Heidi H.
    Siegel, David S.
    BLOOD, 2012, 120 (21)
  • [32] Safety, pharmacokinetic and pharmacodynamic results from dose escalation of SAR439459, a TGFβ inhibitor, as monotherapy or in combination with cemiplimab in a phase 1/1b study.
    Williamson, Stephen K.
    Hodi, F. Stephen
    Johnson, Melissa Lynne
    Barve, Minal A.
    Juric, Dejan
    Baranda, Joaquina Celebre
    Schneider, Reva Elaine
    Bauer, Todd Michael
    Lin, Tun Tun
    Wang, Rui
    Amrate, Amele
    Guillemin-Paveau, Helene
    Sullivan, Ryan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] A Phase 1b Study of Vadastuximab Talirine As Maintenance and in Combination with Standard Consolidation for Patients with Acute Myeloid Leukemia (AML)
    Yang, Jay
    Ravandi, Farhad
    Advani, Anjali
    Vasu, Sumithira
    Walter, Roland B.
    Faderl, Stefan
    Stein, Anthony S.
    Erba, Harry P.
    Fathi, Amir T.
    Donnellan, William B.
    Levy, Moshe Y.
    Smith, Scott E.
    Wood, Brent L.
    Feldman, Eric J.
    Voellinger, Jenna L.
    Maris, Michael B.
    BLOOD, 2016, 128 (22)
  • [34] A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome
    Koo, Ray Mun
    Wong, Eric
    Davis, Joanne E.
    Perera, Travis
    Lim, Andrew
    Koldej, Rachel M.
    Ritchie, David S.
    BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 1025 - 1027
  • [35] A phase 1B dose escalation study of ETC-159 in combination with pembrolizumab in advanced or metastatic solid tumours
    Tan, David Shao Peng
    Ng, Matthew C. H.
    Subbiah, Vivek
    Messersmith, Wells A.
    Strickler, John H.
    Diermayr, Veronica
    Cometa, Julienne
    Blanchard, Stephanie
    Nellore, Ranjani
    Pendharkar, Vishal
    Gan, Bong Hwa
    Rozaini, Nurul Nazihah
    Koh, Claudia
    Sarma, Suman
    Poh, Huay Mei
    Lezhava, Alexander
    Prativadibhayankaram, Venkateshan Srirangam
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer
    Alejandra T. Perez
    Banu Arun
    Debu Tripathy
    Mary A. Tagliaferri
    Heather S. Shaw
    Gretchen G. Kimmick
    Isaac Cohen
    Emma Shtivelman
    Katherine A. Caygill
    Deborah Grady
    Mark Schactman
    Charles L. Shapiro
    Breast Cancer Research and Treatment, 2010, 120 : 111 - 118
  • [37] A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer
    Perez, Alejandra T.
    Arun, Banu
    Tripathy, Debu
    Tagliaferri, Mary A.
    Shaw, Heather S.
    Kimmick, Gretchen G.
    Cohen, Isaac
    Shtivelman, Emma
    Caygill, Katherine A.
    Grady, Deborah
    Schactman, Mark
    Shapiro, Charles L.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (01) : 111 - 118
  • [38] Results from a dose escalation phase 1b study of palbociclib and avelumab in advanced breast cancer in the PAveMenT Trial
    Okines, Alicia F.
    Moghadam, Houman
    Sparks, Laura
    Mohammed, Kabir
    Dunne, Kathryn
    Nerurkar, Ashutosh
    Osin, Peter
    Swift, Claire
    Sardinha, Ruth
    Turner, Nicholas
    CANCER RESEARCH, 2023, 83 (05)
  • [39] Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination With Azacitidine for the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 14 - 16
  • [40] Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naive, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results
    Wei, Andrew H.
    Garcia, Jacqueline S.
    Borate, Uma
    Fong, Chun Yew
    Baer, Maria R.
    Nowak, Daniel
    Peterlin, Pierre
    Jurcic, Joseph
    Jacoby, Meagan A.
    Platzbecker, Uwe
    Odenike, Olatoyosi
    Cunningham, Ilona
    Zhou, Ying
    Hoffman, David
    Hogdal, Leah
    Naqvi, Kiran
    Kye, Steve
    Garcia-Manero, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S343 - S343
12345